.png)
Mankind Pharma has completed a multi-year transformation of its global supply chain and procurement operations, cutting stock-outs by 75% and strengthening medicine access across 25+ international markets with AI-powered planning tools.
.jpeg)
Thermo Fisher partners with Datavant to enhance clinical research by connecting real-world data (RWD) and speeding up evidence generation for biotech and pharma companies.
Cipla Foundation and IISc have launched a Centre for Pulmonary Medicine in Bengaluru, offering advanced care, research, and training to tackle India’s rising respiratory health challenges.
Sanofi has received FDA breakthrough therapy designation for Wayrilz to treat warm autoimmune hemolytic anemia, a rare disorder with no approved targeted therapies. Japan has also granted orphan status.
.jpeg)
MedGenome launches MetaSeq, an advanced blood test using NGS to detect 1,400+ pathogens in just five days, offering faster, more accurate diagnosis for bloodstream infections.
.png)
Pfizer’s Hympavzi (marstacimab) has received FDA Priority Review for treating haemophilia A or B patients aged 6 and older with inhibitors, as well as paediatric patients (ages 6-11) without inhibitors.
.png)
Lupin Pharmaceuticals has officially launched its epilepsy drug, Lacosamide, in the U.S., offering a new treatment option for adults with partial-onset seizures. This generic version of Vimpat is approved by the FDA and strengthens Lupin’s U.S. portf
Pfizer announced positive phase 2b results for PF’3944, showing that monthly dosing delivered up to 12.3% placebo-adjusted weight loss while maintaining safety in adults with obesity or overweight without diabetes.
Lupin partners with TB Alliance to fast-track the clinical development and commercialization of Telacebec for treating TB, leprosy, and other mycobacterial infections.
Eli Lilly and Repertoire Immune Medicines have joined forces in a $1.93B deal to develop next-gen autoimmune therapies, aiming to restore immune balance without broad suppression.
, CDSCO.jpg)